99-25904. Manufacturer of Controlled Substances; Notice of Registration  

  • [Federal Register Volume 64, Number 193 (Wednesday, October 6, 1999)]
    [Notices]
    [Page 54357]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-25904]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF JUSTICE
    
    Drug Enforcement Administration
    
    
    Manufacturer of Controlled Substances; Notice of Registration
    
        By Notice dated May 12, 1999, and published in the Federal Register 
    on may 25, 1999, (64 FR 28214), Research Triangle Institute, Kenneth H. 
    Davis, Jr., Hermann Building, East Institute Drive, P.O. Box 12194, 
    Research Triangle Park, North Carolina 27709, made application by 
    renewal to the Drug Enforcement Administration (DEA) to be registered 
    as a bulk manufacturer of the basic classes of controlled substances 
    listed below:
    
    ------------------------------------------------------------------------
                        Drug                               Schedule
    ------------------------------------------------------------------------
    Marihuana (7360)...........................  I
    Cocaine (9041).............................  II
    ------------------------------------------------------------------------
    
        The institute will manufacture marijuana cigarettes for the 
    National Institute on Drug Abuse (NIDA) and the cocaine will be used 
    for reference standards, human and animal research, as dictated by 
    NIDA.
        No comments or objections have been received. DEA has considered 
    the factors in Title 21, United States Code, Section 823(a) and 
    determined that the registration of Research Triangle Institute to 
    manufacture the listed controlled substances is consistent with the 
    public interest at this time. DEA has investigated Research Triangle 
    Institute on a regular basis to ensure that the company's continued 
    registration is consistent with the public interest. These 
    investigations have included inspection and testing of the company's 
    physical security systems, audits of the company's records, 
    verification of the company's compliance with state and local laws, and 
    a review of the company's background and history. Therefore, pursuant 
    to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant 
    Administrator, Office of Diversion Control, hereby orders that the 
    application submitted by the above firm for registration as a bulk 
    manufacturer of the basis classes of controlled substances listed above 
    is granted.
    
        Dated: September 24, 1999.
    John H. King,
    Deputy Assistant Administrator, Office of Diversion Control, Drug 
    Enforcement Administration.
    [FR Doc. 99-25904 Filed 10-5-99; 8:45 am]
    BILLING CODE 4410-09-M
    
    
    

Document Information

Published:
10/06/1999
Department:
Drug Enforcement Administration
Entry Type:
Notice
Document Number:
99-25904
Pages:
54357-54357 (1 pages)
PDF File:
99-25904.pdf